Completed
Vestipitant 28-day Tolerance Study
NCT00992160
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +7 more
- Locations
-
- GSK Investigational Site Hamburg, Free and Hanseatic City of Hamburg, Germany
- GSK Investigational Site Hamburg, Free and Hanseatic City of Hamburg, Germany
- GSK Investigational Site Kassel, Hesse, Germany
- GSK Investigational Site Hanover, Lower Saxony, Germany